Author:
Sorbo Maria C.,Cento Valeria,Di Maio Velia C.,Howe Anita Y.M.,Garcia Federico,Perno Carlo F.,Ceccherini-Silberstein Francesca
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference182 articles.
1. Recommendations for Testing, Managing, and Treating Hepatitis C;AASLD-IDSA,2018
2. Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infection;Abergel;Hepatology,2016
3. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N. Engl. J. Med.,2014
4. Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance;Ali;ACS Chem. Biol.,2013
5. ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection;Andreone;Gastroenterology,2014
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献